News
Anaptys Announces Positive Rosnilimab Data Updated Through Six Months in Robust Phase 2b Trial in RA
Favorable safety and tolerability, particularly when compared to standard of care biologics or JAKs Max response rates have not yet been observed; strict continuation criteria at three months in this ...
14h
South Africa Today on MSNBiologics: A Revolutionary Leap in MedicineFor decades, pharmaceutical research has centred around developing chemical compounds to treat diseases. Scientists in lab ...
Immune cells play fundamental roles in the development, progression, and resolution of both chronic inflammatory diseases and various cancer types. In ...
Individuals with RA are significantly more likely to develop sleep disorders, particularly insomnia, compared with the general population.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results